Merck today announced a € 70 million expansion of its ADC manufacturing capabilities and capacity in St. Louis, Missouri, USA.
Triples manufacturing capacity to meet increased global demand for antibody-drug conjugates (ADCs)
Reinforces position as first commercially approved contract development and manufacturing organization (CDMO) for ADCs in North America
Expansion to create 170 jobs at Bioconjugation Center of Excellence in St. Louis, Missouri, USA
Blog by Professor Frédéric Barbut, medical microbiologist, Assistance Publique-Hôpitaux de Paris, hôpital Saint-Antoine, Paris
Did you know that we all carry many millions of bacteria on our hands? Anything between 100 to 1,000,000 per square centimetre of skin! But before you start to panic, rest assured that many of these bacteria occur naturally, along with fungi and viruses, and are normally harmless (or ‘not pathogenic’ to use the scientific term). They are known as ‘resident microflora’ and can actually be beneficial in protecting us from infection. Common strains include Staphylococcus and Micrococcus.
M-Trace® Electronic Test Record Software offers digital cleanroom-friendly solution for sterility testing
Digitizes pharmaceutical microbial quality control workflows
Enables complete, real-time, comprehensive data traceability and regulatory compliance, reducing deviations and human error
Partnership to facilitate collaborative research in academia and industry to further progress in life sciences.
Partnership to facilitate collaborative research in academia and industry to further progress in life sciences
Multi-dimensional program to build local research capability and startup ecosystem as well as joint R&D projects
Further example of Merck’s close cooperation with Korea, following the recent € 300 million bioprocessing investment in Daejeon
Global software developer eschbach, the provider of the Shiftconnector® enterprise manufacturing platform for the process industry, has a module, Shiftconnector® Equipment Hub. Designed for the pharmaceutical industry, the Equipment Hub ensures data integrity, simplifies search and retrieval across logs for audits and inspections, and streamlines compliance reporting.
Award-winning technology combines a bioreactor and a centrifuge into one single vessel for the first time, a new approach gentler to patient cells during process steps.
High-flow, biocompatible PBT grade to be shown at NPE2024
New VALOX™ HX325HP resin meets international standards of biocompatibility and change management.
This unreinforced polybutylene terephthalate (PBT) resin has predictable processing and performance properties, including excellent mold release, flexible sterilization options and high environmental stress cracking (ESC) resistance.
It addresses a growing need for medical devices that enable more-convenient and personalized insulin administration and glucose monitoring by patients.
At HANNOVER MESSE 2024, QI-Digital will be showing two demonstrators from the "AI in Medicine" pilot project: a testing platform for AI algorithms and an open-source MRI that can be built cost-effectively thanks to AI.
German Chancellor Olaf Scholz emphasizes significance for Germany as research location at cornerstone laying ceremony
Research center to accelerate biopharmaceutical product development
Part of Merck’s € 1.5 billion investment program in Darmstadt by 2025
Showcases how studies have probed different facets of hand drying and their impact on hygiene and cleanliness
The S700 shoulder exoskeleton from exoIQ is an innovative, ergonomic aid. It provides active support during tiring activities at chest height and overhead work. It relieves the muscles in the shoulders, arms and neck. Tools or your own arms feel almost weightless.
We have 128 guests and no members online
Deutsch (Germany) 
Polski (PL) 
